Hikma Pharmaceuticals Plc Stock Today

HKMPF Stock  USD 26.64  0.14  0.53%   

Performance

4 of 100

 
Weak
 
Strong
Insignificant

Odds Of Distress

Less than 9

 
High
 
Low
Low
Hikma Pharmaceuticals is trading at 26.64 as of the 1st of February 2025. This is a 0.53 percent increase since the beginning of the trading day. The stock's lowest day price was 26.64. Hikma Pharmaceuticals has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. The performance scores are derived for the period starting the 5th of August 2024 and ending today, the 1st of February 2025. Click here to learn more.
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company was founded in 1978 and is based in London, the United Kingdom. Hikma Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. The company has 220.26 M outstanding shares. More on Hikma Pharmaceuticals PLC

Moving against Hikma Pink Sheet

  0.48AA Alcoa CorpPairCorr
  0.44ZTLLF ZonetailPairCorr
  0.39INTC IntelPairCorr
  0.37XOM Exxon Mobil Corp Fiscal Year End 7th of February 2025 PairCorr
  0.36HPQ HP IncPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Hikma Pink Sheet Highlights

ChairmanMazen Darwazah
Business ConcentrationDrug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Hikma Pharmaceuticals PLC [HKMPF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.6 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hikma Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Hikma Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Hikma Pharmaceuticals PLC classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 220.26 M outstanding shares. Hikma Pharmaceuticals PLC has accumulated about 393 M in cash with 638 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.78.
Check Hikma Pharmaceuticals Probability Of Bankruptcy
Ownership Allocation
Hikma Pharmaceuticals PLC has a total of 220.26 Million outstanding shares. Hikma Pharmaceuticals secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Hikma Ownership Details

Hikma Pharmaceuticals PLC Risk Profiles

Hikma Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Hikma Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Breakdown Now

   

Idea Breakdown

Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
All  Next Launch Module

Hikma Pharmaceuticals Corporate Management

Other Information on Investing in Hikma Pink Sheet

Hikma Pharmaceuticals financial ratios help investors to determine whether Hikma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hikma with respect to the benefits of owning Hikma Pharmaceuticals security.